Sudeep Pharma Schedules Q2FY26 Earnings Call for December 22, 2025
Sudeep Pharma Limited has announced an earnings conference call to discuss Q2FY26 operational and financial performance, scheduled for December 22, 2025, at 11:30 AM IST. The call will review the company's performance for the quarter and half-year ended September 30, 2025. Senior management, including Director Shanil Bhayani and CFO Ketan Vyas, will present results and address investor queries. ICICI Securities is coordinating the call using the Diamond Pass registration system.
*this image is generated using AI for illustrative purposes only.
Sudeep Pharma Limited has announced an earnings conference call with analysts and investors to discuss its Q2FY26 operational and financial performance. The call is scheduled for December 22, 2025.
Conference Call Details
The earnings call is organized to review the company's performance for the quarter and half-year ended September 30, 2025. Key details of the conference call are outlined below:
| Parameter | Details |
|---|---|
| Date | Monday, December 22, 2025 |
| Time | 11:30 AM IST |
| Platform | Diamond Pass registration system |
| Coordinator | ICICI Securities |
Management Representation
The conference call will feature senior management personnel who will present the company's quarterly results and address investor queries. The management team includes:
- Mr. Shanil Bhayani - Director
- Mr. Ketan Vyas - Chief Financial Officer
Registration and Contact Information
ICICI Securities is coordinating the Q2FY26 results conference call, with multiple contact persons available for registration and clarifications. The call coordination team includes Mr. Jaideep Goswami (Head of Equities), Mr. Sanjesh Jain, and Mr. Mohit Mishra, along with additional support staff for technical assistance.
Regulatory Compliance
Sudeep Pharma Limited has fulfilled its disclosure obligations by informing both the National Stock Exchange of India Limited and BSE Limited about the scheduled earnings call. The company's scrip symbol is SUDEEPPHRM with BSE scrip code 544619. The earnings call invite has been made available on the company's official website at https://www.sudeeppharma.com/ for broader accessibility.
Company Information
The pharmaceutical company, incorporated under CIN U24231GJ1989PLC013141, operates from its registered office in Nandesari, Baroda, Gujarat, with corporate offices located in Vadodara. The announcement was signed by Ms. Dimple Mehta, Company Secretary and Compliance Officer, ensuring proper regulatory compliance for the earnings disclosure process.
Historical Stock Returns for Sudeep Pharma
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -4.16% | +2.86% | -13.50% | -13.50% | -13.50% | -13.50% |
16
